Driving change through England’s Rare Diseases Action Plans | LATSS 2026

Speaker: Kath Bainbridge (Office for Life Sciences) Synopsis: The fifth England Rare Diseases Action Plan was published on 27 February 2026. In this action plan we recognise rare diseases as a health inequality and introduce a new action to address this. The action plan reports on progress across the four priorities of the framework. Highlights include: MHRA’s commitments to major reform in regulation of rare therapies NICE’s publication of a new quality standard for rare diseases the development of a new NHS framework for individualised genetic therapies new funding for 2 pilot centres for people with undiagnosed rare conditions This talk will reflect on progress over the last five years and what should follow when the Framework expires in January 2027. This talk was recorded at the LifeArc Translational Science Summit 2026. ------------------------------------- LifeArc is a self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections. We aim to deliver this by conducting and funding pioneering research, and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments. Our vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster. Find out more at lifearc.org

Gene therapy for Huntington’s disease | LATSS 2026
▶︎

Gene therapy for Huntington’s disease | LATSS 2026

The assessment of mood following severe acquired brain injury - Alex Rose
▶︎

The assessment of mood following severe acquired brain injury - Alex Rose

Personalised genetic medicines for rare diseases: potential challenges | LATSS 2026
▶︎

Personalised genetic medicines for rare diseases: potential challenges | LATSS 2026

Securing sustainable access - NHS England’s strategy for rare disease medicines | LATSS 2026
▶︎

Securing sustainable access - NHS England’s strategy for rare disease medicines | LATSS 2026

Expanding Research Through Health Data and Collaboration:January 2023-UofL Research Town Hall Meetin
▶︎

Expanding Research Through Health Data and Collaboration:January 2023-UofL Research Town Hall Meetin

The AI Skills Nobody is Teaching (And Everyone Needs) | AI Expert Ethan Mollick
▶︎

The AI Skills Nobody is Teaching (And Everyone Needs) | AI Expert Ethan Mollick

Justin Wolfers on the economic absurdities of Trump's America | That's Business with Alan Kohler
▶︎

Justin Wolfers on the economic absurdities of Trump's America | That's Business with Alan Kohler

New models for rare disease drug development and commercialisation | LATSS 2026
▶︎

New models for rare disease drug development and commercialisation | LATSS 2026

What psychological aspects are we missing in FCD - Sarah Cope
▶︎

What psychological aspects are we missing in FCD - Sarah Cope

The Brain Diabetes Project – Claire McEvoy, QUB
▶︎

The Brain Diabetes Project – Claire McEvoy, QUB

Deep Tech Atelier side event  “Industrijas izaicinājumi zinātnei”
▶︎

Deep Tech Atelier side event “Industrijas izaicinājumi zinātnei”

Commercial value need not be rare: why today’s companies and investors should be in rare disease
▶︎

Commercial value need not be rare: why today’s companies and investors should be in rare disease

Hunter syndrome, how to apply lessons learned when treating similar diseases | LATSS 2026
▶︎

Hunter syndrome, how to apply lessons learned when treating similar diseases | LATSS 2026

The Miracles (and Maddening Politics) of the Clean Energy Revolution | The Ezra Klein Show
▶︎

The Miracles (and Maddening Politics) of the Clean Energy Revolution | The Ezra Klein Show

Research into awareness & understanding of brain health & dementia risk factors – Fiona Foley, NDS
▶︎

Research into awareness & understanding of brain health & dementia risk factors – Fiona Foley, NDS

Naomi Klein On Heatwaves, China, and The Danger Of Technofixes
▶︎

Naomi Klein On Heatwaves, China, and The Danger Of Technofixes

Innovating the future of health: from diagnostics to delivery
▶︎

Innovating the future of health: from diagnostics to delivery

Wall Street Is Pumping SpaceX — So Why Is It Falling?
▶︎

Wall Street Is Pumping SpaceX — So Why Is It Falling?

The cost and opportunity of rare disease | LATSS 2026
▶︎

The cost and opportunity of rare disease | LATSS 2026

‘PTCy – for ALL donors?’ w. Leo Luznik
▶︎

‘PTCy – for ALL donors?’ w. Leo Luznik